- Trials with a EudraCT protocol (533)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
533 result(s) found for: Drug Approval.
Displaying page 1 of 27.
EudraCT Number: 2017-001678-40 | Sponsor Protocol Number: CACZ885N2301E2 | Start Date*: 2017-05-15 | |||||||||||
Sponsor Name:Novartis pharma AG | |||||||||||||
Full Title: An extension study of safety of canakinumab in Japanese patients with periodic fever syndromes | |||||||||||||
Medical condition: Three disease of periodic fever syndromes, TNF receptor Associated Periodic Syndrome (TRAPS), Hyper IgDSyndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD) and Familial Mediterranean Fever (FMF | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005103-39 | Sponsor Protocol Number: AP01-005 | Start Date*: 2021-04-16 | |||||||||||
Sponsor Name:Avalyn Pharma, Inc. | |||||||||||||
Full Title: Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis | |||||||||||||
Medical condition: Interstitial Lung Diseases (ILD), including but not limited to idiopathic pulmonary fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) NL (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004335-39 | Sponsor Protocol Number: N01223 | Start Date*: 2015-02-16 | |||||||||||
Sponsor Name:UCB Japan Co. Ltd. | |||||||||||||
Full Title: An Open Label, Single-Arm, Multi-Center Study on the Efficacy, Safety and Pharmacokinetics of Levetiracetam in Pediatric Patients (4 to 16 Years) With Partial Seizures Despite Treatment With 1 or 2... | |||||||||||||
Medical condition: Epilepsy Partial Seizures | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000954-67 | Sponsor Protocol Number: ATB200-07 | Start Date*: 2020-04-08 | |||||||||||
Sponsor Name:Amicus Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease | |||||||||||||
Medical condition: Adult Subjects With Late Onset Pompe Disease (LOPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) DE (Completed) DK (Ongoing) FR (Ongoing) BE (Ongoing) GR (Ongoing) SI (Ongoing) AT (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006076-38 | Sponsor Protocol Number: RLBUHT3173 | Start Date*: 2007-04-26 |
Sponsor Name:University of Liverpool [...] | ||
Full Title: The Liverpool HIV TDM Registry: Studying influences upon plasma HIV drug exposure | ||
Medical condition: Pharmacogenetic study of HIV+ patients receiving antiretroviral therapy. We wish to correlate drug concentration with host genetic patients receiving certain HIV drugs. No dosage modification wil... | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001046-17 | Sponsor Protocol Number: SMART-2019 | Start Date*: 2019-05-02 | |||||||||||
Sponsor Name:Uppsala University | |||||||||||||
Full Title: A multicentre, register-based, randomized, controlled trial comparing dapagliflozin with metformin treatment in early stage type 2 diabetes patients by assessing mortality and macro- and microvascu... | |||||||||||||
Medical condition: Type 2 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002996-34 | Sponsor Protocol Number: PK 2005 xx | Start Date*: 2006-04-27 |
Sponsor Name:University Hospitals of Leicester NHS Trust | ||
Full Title: Pharmacokinetics of actinomycin D in children with cancer | ||
Medical condition: Any children's cancer where this drug is administered as part of the treatment regimen | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001018-13 | Sponsor Protocol Number: BCX1812-305 | Start Date*: 2021-03-31 | |||||||||||
Sponsor Name:BioCryst Pharmaceuticals Inc | |||||||||||||
Full Title: A Phase 3, Randomized, Open Label, Active-controlled Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of IV Peramivir Compared to Oral Oseltamivir in Pediatric Subjects With Acute U... | |||||||||||||
Medical condition: acute uncomplicated influenza | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019866-96 | Sponsor Protocol Number: IPM3001 | Start Date*: 2010-12-07 |
Sponsor Name:ZIOPHARM Oncology Inc | ||
Full Title: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of doxorubicin plus palifosfamide-tris vs. doxorubicin plus placebo in patients with front-line metastatic... | ||
Medical condition: metastatic soft tissue sarcomas, previously untreated | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) GB (Prematurely Ended) ES (Ongoing) IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005396-25 | Sponsor Protocol Number: D3250C00037 | Start Date*: 2016-06-22 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Multicenter, Open-label, Safety Extension Study with Benralizumab (MEDI-563) for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist (MELTEMI) | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DE (Completed) CZ (Completed) PL (Completed) BG (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004129-18 | Sponsor Protocol Number: AK581 | Start Date*: 2017-03-17 | ||||||||||||||||
Sponsor Name:Akari Therapeutics Plc | ||||||||||||||||||
Full Title: CONSERVE: rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study | ||||||||||||||||||
Medical condition: Paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemic syndrome (aHUS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) PL (Prematurely Ended) NL (Prematurely Ended) LT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001768-60 | Sponsor Protocol Number: CNS 2007 04 | Start Date*: 2007-10-01 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide with Radiotherapy in Diffuse Pontine Gliomas | |||||||||||||
Medical condition: Diffuse pontine glioma in children | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002880-42 | Sponsor Protocol Number: LAL-CL05 | Start Date*: 2011-12-05 | |||||||||||||||||||||
Sponsor Name:Synageva Biopharma Corp. | |||||||||||||||||||||||
Full Title: An Open Label Multicenter Extension Study to Evaluate the Long-Term Efficacy and Safety of SBC 102 in Children with Lysosomal Acid Lipase Deficiency Who Previously Received Treatment with SBC-102 | |||||||||||||||||||||||
Medical condition: Growth failure in children due to lysosomal acid lipase deficiency (Wolman disease). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) FR (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003916-19 | Sponsor Protocol Number: 001 | Start Date*: 2015-12-30 |
Sponsor Name:Karl Landsteiner Institut für klinische Neurologie und Neuropsycholigie | ||
Full Title: Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy | ||
Medical condition: Data on perioperative seizure prophylaxis in brain tumor patients as weil as on specific side effects is limited in scientific literature. Epileptic seizures during and after brain tumor surgery ma... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001319-30 | Sponsor Protocol Number: CH/2011/3670 | Start Date*: 2012-04-04 | |||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | |||||||||||||
Full Title: A randomized, double-blind, parallel group, placebo-controlled trial of metformin in tuberous sclerosis complex. | |||||||||||||
Medical condition: Tuberous Sclerosis Complex | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000788-27 | Sponsor Protocol Number: RD01273 | Start Date*: 2006-04-20 |
Sponsor Name:Royal United Hospital Bath NHS Trust | ||
Full Title: International Collaborative Infantile Spasms Study (ICISS) | ||
Medical condition: Infantile spasms are a rare severe form of epilepsy affecting approx 1 in 2,250 infants, usually under the age of 1 year. Affected infants have a very abnormal EEG and a poor prognosis for subseque... | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000451-41 | Sponsor Protocol Number: HO150 | Start Date*: 2019-03-01 | ||||||||||||||||
Sponsor Name:HOVON Foundation | ||||||||||||||||||
Full Title: A phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib or enasidenib in combination with induction therapy and consolidation therapy followed by maintenance therap... | ||||||||||||||||||
Medical condition: AML or MDS-EB2 with a mutation in either IDH1 or IDH2 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) FI (Ongoing) LT (Ongoing) SE (Ongoing) BE (Ongoing) FR (Temporarily Halted) NO (Ongoing) IE (Ongoing) DE (Ongoing) AT (Ongoing) DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004522-16 | Sponsor Protocol Number: DU176b-C-U301 | Start Date*: 2009-05-20 | |||||||||||
Sponsor Name:Daiichi Sankyo Pharma Development | |||||||||||||
Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MULTI-CENTER, MULTI-NATIONAL STUDY FOR EVALUATION OF EFFICACY AND SAFETY OF DU-176B VERSUS WARFARIN IN SUBJECTS WITH ATRIAL FIBRIL... | |||||||||||||
Medical condition: Reduction of Stroke and/or systemic embolic event (SEE) in subjects with atrial fibrillation (AF). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) GB (Completed) SE (Completed) EE (Completed) FI (Completed) NL (Completed) PT (Completed) DK (Completed) ES (Completed) CZ (Completed) IT (Completed) BG (Completed) HU (Completed) SK (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004108-16 | Sponsor Protocol Number: HOFATA_v3.0 | Start Date*: 2022-04-21 |
Sponsor Name:Medical University Vienna | ||
Full Title: Host factors predicting target site concentration of antibiotics in critically ill patients: An explorative pharmacokinetic biomarker study | ||
Medical condition: All patients given standard of care intravenous therapy of the studied antibiotics will be screened against the inclusion criteria. Two groups are included: Group A (septic patients with organ dysf... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002845-36 | Sponsor Protocol Number: PK200609 | Start Date*: 2006-11-14 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Pharmacokinetics and pharmacogenetics of anticancer drugs in infants and young children | ||
Medical condition: Any childhood cancer. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.